RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TASSORELLI C
Collezione AOU Alessandria

Items : 3

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study). in Cephalalgia : an international journal of headache / Cephalalgia. 2026 Feb;46(2):3331024251414659. doi: 10.1177/03331024251414659. Epub 2026 Feb 12.

2026
AOU Alessandria

Iannone LF; Piella EM; Montisano DA; Fasano C; Sebastianelli G; Coppola G; Ferrandi D; Lanni C; Prudenzano MP; de Tommaso M; Merlo P; De Cesaris F; Chiarugi A; Munafò A; Pistoia F; Ornello R; Doretti A; Grazzi L; Lo Castro F; De Icco R; Vaghi G; Avino G; Romozzi M; Calabresi P; Battistini S; Rufa A; Albanese M; Trimboli M; Carlucci G; et alii...

Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study. in Cephalalgia : an international journal of headache / Cephalalgia. 2024 Nov;44(11):3331024241299453. doi: 10.1177/03331024241299453.

2024
AOU Alessandria

Dalla Volta G; Russo A; Silvestro M; Ornello R; Caponnetto V; Sacco S; Zavarise P; Cortinovis M; Lo Castro F; Guerzoni S; Prudenzano MP; Gentile M; De Icco R; Vaghi G; Tassorelli C; De Tommaso M; Scannicchio S; Rainero I; Granato A; Sepe FN; Ferrandi D; Rebecchi V; Alessandri M; Burgalassi A; Romozzi M; Casalena A; Chiarugi A; Geppetti P; Iannone LF; et alii...

Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study. in CNS drugs / CNS Drugs. 2023 Dec;37(12):1069-1080. doi: 10.1007/s40263-023-01050-3. Epub 2023 Nov 24.

2023
AOU Alessandria

Caponnetto V; Russo A; Silvestro M; Tessitore A; De Icco R; Vaghi G; Sances G; Tassorelli C; Baraldi C; Castro FL; Guerzoni S; Prudenzano MP; Fallacara A; Gentile M; Ornello R; Onofri A; Burgalassi A; Chiarugi A; De Cesaris F; Granato A; Casalena A; De Tommaso M; Mampreso E; Merlo P; Coppola G; Battistini S; Rebecchi V; Rainero I; Sepe FN; et alii...